 | • レポートコード：20QY06-06752 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、心不全治療のグローバル市場について種類別（診断、予後、治療オプション・治療アルゴリズム）、用途別（病院、クリニック、医療研究機構）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・心不全治療市場の概要 ・世界の主要地域別心不全治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の心不全治療市場規模2015-2026：種類別（診断、予後、治療オプション・治療アルゴリズム） ・世界の心不全治療市場規模2015-2026：用途別（病院、クリニック、医療研究機構） ・心不全治療の北米市場規模2015-2020 ・心不全治療のヨーロッパ市場規模2015-2020 ・心不全治療の中国市場規模2015-2020 ・心不全治療の日本市場規模2015-2020 ・心不全治療の東南アジア市場規模2015-2020 ・心不全治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bayer、Cynokinetics、Les Laboratoires Servier、Merck & Co.、Novartis、Procoralan、Bristol-Myers Squibb Company、Cardiorentis AG、CVie Therapeutics Limited、Orion Corporation、PhaseBio Pharmaceuticals、Market Segment by Product Type、B-Blockers、Calcium Channel Blockers、Cardiac Glycosides、Diuretics、Morphine、Vasodilators/Nitrates） ・心不全治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・心不全治療の市場動向・機会・課題 ・調査の結論 |
Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body’s needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart failure.
Market Analysis and Insights: Global Heart Failure Therapeutics Market
The global Heart Failure Therapeutics market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Heart Failure Therapeutics Scope and Market Size
The global Heart Failure Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Heart Failure Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Heart Failure Therapeutics market is segmented into
Diagnosis
Prognosis
Treatment Options and Treatment Algorithm
Segment by Application, the Heart Failure Therapeutics market is segmented into
Hospital
Clinic
Medical Research Organization
The Heart Failure Therapeutics market is analysed and market size information is provided by regions (countries). Segment by Application, the Heart Failure Therapeutics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Heart Failure Therapeutics Market Share Analysis
Heart Failure Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Heart Failure Therapeutics business, the date to enter into the Heart Failure Therapeutics market, Heart Failure Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals
Market Segment by Product Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Table of Contents
1 Heart Failure Therapeutics Market Overview
1.1 Heart Failure Therapeutics Product Scope
1.2 Heart Failure Therapeutics Segment by Type
1.2.1 Global Heart Failure Therapeutics Sales by Type (2020-2026)
1.2.2 Diagnosis
1.2.3 Prognosis
1.2.4 Treatment Options and Treatment Algorithm
1.3 Heart Failure Therapeutics Segment by Application
1.3.1 Global Heart Failure Therapeutics Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Research Organization
1.4 Heart Failure Therapeutics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Heart Failure Therapeutics Sales Growth Rate (2015-2026)
1.4.2 Global Heart Failure Therapeutics Revenue and Growth Rate (2015-2026)
1.4.3 Global Heart Failure Therapeutics Price Trends (2015-2026)
2 Heart Failure Therapeutics Estimate and Forecast by Region
2.1 Global Heart Failure Therapeutics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Heart Failure Therapeutics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Heart Failure Therapeutics Sales Market Share by Region (2015-2020)
2.2.2 Global Heart Failure Therapeutics Revenue Market Share by Region (2015-2020)
2.3 Global Heart Failure Therapeutics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Heart Failure Therapeutics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Heart Failure Therapeutics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Heart Failure Therapeutics Estimates and Projections (2015-2026)
2.4.2 Europe Heart Failure Therapeutics Estimates and Projections (2015-2026)
2.4.3 China Heart Failure Therapeutics Estimates and Projections (2015-2026)
2.4.4 Japan Heart Failure Therapeutics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Heart Failure Therapeutics Estimates and Projections (2015-2026)
2.4.6 India Heart Failure Therapeutics Estimates and Projections (2015-2026)
3 Global Heart Failure Therapeutics Competition Landscape by Players
3.1 Global Top Heart Failure Therapeutics Players by Sales (2015-2020)
3.2 Global Top Heart Failure Therapeutics Players by Revenue (2015-2020)
3.3 Global Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Therapeutics as of 2019)
3.4 Global Heart Failure Therapeutics Average Price by Company (2015-2020)
3.5 Manufacturers Heart Failure Therapeutics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Heart Failure Therapeutics Players (Opinion Leaders)
4 Global Heart Failure Therapeutics Market Size by Type
4.1 Global Heart Failure Therapeutics Historic Market Review by Type (2015-2020)
4.1.1 Global Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
4.1.2 Global Heart Failure Therapeutics Revenue Market Share by Type (2015-2020)
4.1.3 Global Heart Failure Therapeutics Price by Type (2014-2020)
4.2 Global Heart Failure Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Heart Failure Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Heart Failure Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Global Heart Failure Therapeutics Price Forecast by Type (2021-2026)
5 Global Heart Failure Therapeutics Market Size by Application
5.1 Global Heart Failure Therapeutics Historic Market Review by Application (2015-2020)
5.1.1 Global Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
5.1.2 Global Heart Failure Therapeutics Revenue Market Share by Application (2015-2020)
5.1.3 Global Heart Failure Therapeutics Price by Application (2015-2020)
5.2 Global Heart Failure Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Heart Failure Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Heart Failure Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Heart Failure Therapeutics Price Forecast by Application (2021-2026)
3 North America Heart Failure Therapeutics Market Facts & Figures
3.2 North America Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
3.3 North America Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
3.4 North America Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
4 Europe Heart Failure Therapeutics Market Facts & Figures
4.2 Europe Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
4.3 Europe Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
4.4 Europe Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
5 China Heart Failure Therapeutics Market Facts & Figures
5.2 China Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
5.3 China Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
5.4 China Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
6 Japan Heart Failure Therapeutics Market Facts & Figures
6.2 Japan Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
6.3 Japan Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
6.4 Japan Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
7 Southeast Asia Heart Failure Therapeutics Market Facts & Figures
7.2 Southeast Asia Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
8 India Heart Failure Therapeutics Market Facts & Figures
8.2 India Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
8.3 India Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
8.4 India Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Heart Failure Therapeutics Business
12.1 Bayer
12.1.1 Bayer Heart Failure Therapeutics Corporation Information
12.1.2 Bayer Heart Failure Therapeutics Business Overview and Total Revenue
12.1.3 Bayer Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Heart Failure Therapeutics Products Offered
12.1.5 Bayer Recent Development
12.2 Cynokinetics
12.2.1 Cynokinetics Heart Failure Therapeutics Corporation Information
12.2.2 Cynokinetics Heart Failure Therapeutics Business Overview and Total Revenue
12.2.3 Cynokinetics Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cynokinetics Heart Failure Therapeutics Products Offered
12.2.5 Cynokinetics Recent Development
12.3 Les Laboratoires Servier
12.3.1 Les Laboratoires Servier Heart Failure Therapeutics Corporation Information
12.3.2 Les Laboratoires Servier Heart Failure Therapeutics Business Overview and Total Revenue
12.3.3 Les Laboratoires Servier Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Les Laboratoires Servier Heart Failure Therapeutics Products Offered
12.3.5 Les Laboratoires Servier Recent Development
12.4 Merck & Co.
12.4.1 Merck & Co. Heart Failure Therapeutics Corporation Information
12.4.2 Merck & Co. Heart Failure Therapeutics Business Overview and Total Revenue
12.4.3 Merck & Co. Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck & Co. Heart Failure Therapeutics Products Offered
12.4.5 Merck & Co. Recent Development
12.5 Novartis
12.5.1 Novartis Heart Failure Therapeutics Corporation Information
12.5.2 Novartis Heart Failure Therapeutics Business Overview and Total Revenue
12.5.3 Novartis Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Heart Failure Therapeutics Products Offered
12.5.5 Novartis Recent Development
12.6 Procoralan
12.6.1 Procoralan Heart Failure Therapeutics Corporation Information
12.6.2 Procoralan Heart Failure Therapeutics Business Overview and Total Revenue
12.6.3 Procoralan Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Procoralan Heart Failure Therapeutics Products Offered
12.6.5 Procoralan Recent Development
12.7 Bristol-Myers Squibb Company
12.7.1 Bristol-Myers Squibb Company Heart Failure Therapeutics Corporation Information
12.7.2 Bristol-Myers Squibb Company Heart Failure Therapeutics Business Overview and Total Revenue
12.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bristol-Myers Squibb Company Heart Failure Therapeutics Products Offered
12.7.5 Bristol-Myers Squibb Company Recent Development
12.8 Cardiorentis AG
12.8.1 Cardiorentis AG Heart Failure Therapeutics Corporation Information
12.8.2 Cardiorentis AG Heart Failure Therapeutics Business Overview and Total Revenue
12.8.3 Cardiorentis AG Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Cardiorentis AG Heart Failure Therapeutics Products Offered
12.8.5 Cardiorentis AG Recent Development
12.9 CVie Therapeutics Limited
12.9.1 CVie Therapeutics Limited Heart Failure Therapeutics Corporation Information
12.9.2 CVie Therapeutics Limited Heart Failure Therapeutics Business Overview and Total Revenue
12.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 CVie Therapeutics Limited Heart Failure Therapeutics Products Offered
12.9.5 CVie Therapeutics Limited Recent Development
12.10 Orion Corporation
12.10.1 Orion Corporation Heart Failure Therapeutics Corporation Information
12.10.2 Orion Corporation Heart Failure Therapeutics Business Overview and Total Revenue
12.10.3 Orion Corporation Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Orion Corporation Heart Failure Therapeutics Products Offered
12.10.5 Orion Corporation Recent Development
12.11 PhaseBio Pharmaceuticals
12.11.1 PhaseBio Pharmaceuticals Heart Failure Therapeutics Corporation Information
12.11.2 PhaseBio Pharmaceuticals Heart Failure Therapeutics Business Overview and Total Revenue
12.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.11.4 PhaseBio Pharmaceuticals Heart Failure Therapeutics Products Offered
12.11.5 PhaseBio Pharmaceuticals Recent Development
12.12 Market Segment by Product Type
12.12.1 Market Segment by Product Type Heart Failure Therapeutics Corporation Information
12.12.2 Market Segment by Product Type Heart Failure Therapeutics Business Overview and Total Revenue
12.12.3 Market Segment by Product Type Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Market Segment by Product Type Heart Failure Therapeutics Products Offered
12.12.5 Market Segment by Product Type Recent Development
12.13 B-Blockers
12.13.1 B-Blockers Heart Failure Therapeutics Corporation Information
12.13.2 B-Blockers Heart Failure Therapeutics Business Overview and Total Revenue
12.13.3 B-Blockers Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.13.4 B-Blockers Heart Failure Therapeutics Products Offered
12.13.5 B-Blockers Recent Development
12.14 Calcium Channel Blockers
12.14.1 Calcium Channel Blockers Heart Failure Therapeutics Corporation Information
12.14.2 Calcium Channel Blockers Heart Failure Therapeutics Business Overview and Total Revenue
12.14.3 Calcium Channel Blockers Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Calcium Channel Blockers Heart Failure Therapeutics Products Offered
12.14.5 Calcium Channel Blockers Recent Development
12.15 Cardiac Glycosides
12.15.1 Cardiac Glycosides Heart Failure Therapeutics Corporation Information
12.15.2 Cardiac Glycosides Heart Failure Therapeutics Business Overview and Total Revenue
12.15.3 Cardiac Glycosides Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Cardiac Glycosides Heart Failure Therapeutics Products Offered
12.15.5 Cardiac Glycosides Recent Development
12.16 Diuretics
12.16.1 Diuretics Heart Failure Therapeutics Corporation Information
12.16.2 Diuretics Heart Failure Therapeutics Business Overview and Total Revenue
12.16.3 Diuretics Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Diuretics Heart Failure Therapeutics Products Offered
12.16.5 Diuretics Recent Development
12.17 Morphine
12.17.1 Morphine Heart Failure Therapeutics Corporation Information
12.17.2 Morphine Heart Failure Therapeutics Business Overview and Total Revenue
12.17.3 Morphine Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Morphine Heart Failure Therapeutics Products Offered
12.17.5 Morphine Recent Development
12.18 Vasodilators/Nitrates
12.18.1 Vasodilators/Nitrates Heart Failure Therapeutics Corporation Information
12.18.2 Vasodilators/Nitrates Heart Failure Therapeutics Business Overview and Total Revenue
12.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Vasodilators/Nitrates Heart Failure Therapeutics Products Offered
12.18.5 Vasodilators/Nitrates Recent Development
13 Heart Failure Therapeutics Manufacturing Cost Analysis
13.1 Heart Failure Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Heart Failure Therapeutics
13.4 Heart Failure Therapeutics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Heart Failure Therapeutics Distributors List
14.3 Heart Failure Therapeutics Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Heart Failure Therapeutics Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Heart Failure Therapeutics Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Heart Failure Therapeutics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Heart Failure Therapeutics Sales (K Units) by Region (2015-2020)
Table 5. Global Heart Failure Therapeutics Sales Market Share by Region (2015-2020)
Table 6. Global Heart Failure Therapeutics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Heart Failure Therapeutics Revenue Share by Region (2015-2020)
Table 8. Global Heart Failure Therapeutics Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Heart Failure Therapeutics Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Heart Failure Therapeutics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Heart Failure Therapeutics Revenue Share Forecast by Region (2021-2026)
Table 12. Global Heart Failure Therapeutics (K Units) of Key Companies (2015-2020)
Table 13. Global Heart Failure Therapeutics Sales Share by Company (2015-2020)
Table 14. Global Heart Failure Therapeutics Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Heart Failure Therapeutics Revenue Share by Company (2015-2020)
Table 16. Global Heart Failure Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Therapeutics as of 2019)
Table 17. Global Heart Failure Therapeutics Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Heart Failure Therapeutics Manufacturing Sites and Area Served
Table 19. Manufacturers Heart Failure Therapeutics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Heart Failure Therapeutics Players
Table 22. Global Heart Failure Therapeutics Sales (K Units) by Type (2015-2020)
Table 23. Global Heart Failure Therapeutics Sales Share by Type (2015-2020)
Table 24. Global Heart Failure Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Heart Failure Therapeutics Price (K Units) by Type (2015-2020)
Table 26. Global Heart Failure Therapeutics Sales Share by Type (2021-2026)
Table 27. Global Heart Failure Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Heart Failure Therapeutics Revenue Share by Type (2021-2026)
Table 29. Global Heart Failure Therapeutics Price (K Units) by Type (2021-2026)
Table 30. Global Heart Failure Therapeutics Sales (K Units) by Application (2015-2020)
Table 31. Global Heart Failure Therapeutics Sales Share by Application (2015-2020)
Table 32. Global Heart Failure Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Heart Failure Therapeutics Price (K Units) by Application (2015-2020)
Table 34. Global Heart Failure Therapeutics Sales (K Units) by Application (2021-2026)
Table 35. Global Heart Failure Therapeutics Sales Share by Application (2021-2026)
Table 36. Global Heart Failure Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Heart Failure Therapeutics Revenue Share by Application (2021-2026)
Table 38. Global Heart Failure Therapeutics Price (K Units) by Application (2021-2026)
Table 39. United States Heart Failure Therapeutics Sales (K Units) by Company (2015-2020)
Table 40. United States Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
Table 41. United States Heart Failure Therapeutics Sales (K Units) by Type (2015-2020)
Table 42. United States Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 43. United States Heart Failure Therapeutics Sales (K Units) by Application (2015-2020)
Table 44. United States Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 45. Europe Heart Failure Therapeutics Sales (K Units) by Company (2015-2020)
Table 46. Europe Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
Table 47. Europe Heart Failure Therapeutics Sales (K Units) by Type (2015-2020)
Table 48. Europe Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 49. Europe Heart Failure Therapeutics Sales (K Units) by Application (2015-2020)
Table 50. Europe Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 51. China Heart Failure Therapeutics Sales (K Units) by Company (2015-2020)
Table 52. China Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
Table 53. China Heart Failure Therapeutics Sales (K Units) by Type (2015-2020)
Table 54. China Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 55. China Heart Failure Therapeutics Sales (K Units) by Application (2015-2020)
Table 56. China Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 57. Japan Heart Failure Therapeutics Sales (K Units) by Company (2015-2020)
Table 58. Japan Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
Table 59. Japan Heart Failure Therapeutics Sales (K Units) by Type (2015-2020)
Table 60. Japan Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 61. Japan Heart Failure Therapeutics Sales (K Units) by Application (2015-2020)
Table 62. Japan Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Heart Failure Therapeutics Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Heart Failure Therapeutics Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Heart Failure Therapeutics Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 69. India Heart Failure Therapeutics Sales (K Units) by Company (2015-2020)
Table 70. India Heart Failure Therapeutics Sales Market Share by Company (2015-2020)
Table 71. India Heart Failure Therapeutics Sales (K Units) by Type (2015-2020)
Table 72. India Heart Failure Therapeutics Sales Market Share by Type (2015-2020)
Table 73. India Heart Failure Therapeutics Sales (K Units) by Application (2015-2020)
Table 74. India Heart Failure Therapeutics Sales Market Share by Application (2015-2020)
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bayer Heart Failure Therapeutics Product
Table 79. Bayer Recent Development
Table 80. Cynokinetics Corporation Information
Table 81. Cynokinetics Description and Business Overview
Table 82. Cynokinetics Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Cynokinetics Heart Failure Therapeutics Product
Table 84. Cynokinetics Recent Development
Table 85. Les Laboratoires Servier Corporation Information
Table 86. Les Laboratoires Servier Description and Business Overview
Table 87. Les Laboratoires Servier Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Les Laboratoires Servier Heart Failure Therapeutics Product
Table 89. Les Laboratoires Servier Recent Development
Table 90. Merck & Co. Corporation Information
Table 91. Merck & Co. Description and Business Overview
Table 92. Merck & Co. Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck & Co. Heart Failure Therapeutics Product
Table 94. Merck & Co. Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novartis Heart Failure Therapeutics Product
Table 99. Novartis Recent Development
Table 100. Procoralan Corporation Information
Table 101. Procoralan Description and Business Overview
Table 102. Procoralan Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Procoralan Heart Failure Therapeutics Product
Table 104. Procoralan Recent Development
Table 105. Bristol-Myers Squibb Company Corporation Information
Table 106. Bristol-Myers Squibb Company Description and Business Overview
Table 107. Bristol-Myers Squibb Company Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb Company Heart Failure Therapeutics Product
Table 109. Bristol-Myers Squibb Company Recent Development
Table 110. Cardiorentis AG Corporation Information
Table 111. Cardiorentis AG Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Cardiorentis AG Description and Business Overview
Table 113. Cardiorentis AG Heart Failure Therapeutics Product
Table 114. Cardiorentis AG Recent Development
Table 115. CVie Therapeutics Limited Corporation Information
Table 116. CVie Therapeutics Limited Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. CVie Therapeutics Limited Description and Business Overview
Table 118. CVie Therapeutics Limited Heart Failure Therapeutics Product
Table 119. CVie Therapeutics Limited Recent Development
Table 120. Orion Corporation Corporation Information
Table 121. Orion Corporation Description and Business Overview
Table 122. Orion Corporation Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Orion Corporation Heart Failure Therapeutics Product
Table 124. Orion Corporation Recent Development
Table 125. PhaseBio Pharmaceuticals Corporation Information
Table 126. PhaseBio Pharmaceuticals Description and Business Overview
Table 127. PhaseBio Pharmaceuticals Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product
Table 129. PhaseBio Pharmaceuticals Recent Development
Table 130. Market Segment by Product Type Corporation Information
Table 131. Market Segment by Product Type Description and Business Overview
Table 132. Market Segment by Product Type Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Market Segment by Product Type Heart Failure Therapeutics Product
Table 134. Market Segment by Product Type Recent Development
Table 135. B-Blockers Corporation Information
Table 136. B-Blockers Description and Business Overview
Table 137. B-Blockers Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. B-Blockers Heart Failure Therapeutics Product
Table 139. B-Blockers Recent Development
Table 140. Calcium Channel Blockers Corporation Information
Table 141. Calcium Channel Blockers Description and Business Overview
Table 142. Calcium Channel Blockers Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Calcium Channel Blockers Heart Failure Therapeutics Product
Table 144. Calcium Channel Blockers Recent Development
Table 145. Cardiac Glycosides Corporation Information
Table 146. Cardiac Glycosides Description and Business Overview
Table 147. Cardiac Glycosides Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Cardiac Glycosides Heart Failure Therapeutics Product
Table 149. Cardiac Glycosides Recent Development
Table 150. Diuretics Corporation Information
Table 151. Diuretics Description and Business Overview
Table 152. Diuretics Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Diuretics Heart Failure Therapeutics Product
Table 154. Diuretics Recent Development
Table 155. Morphine Corporation Information
Table 156. Morphine Description and Business Overview
Table 157. Morphine Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Morphine Heart Failure Therapeutics Product
Table 159. Morphine Recent Development
Table 160. Vasodilators/Nitrates Corporation Information
Table 161. Vasodilators/Nitrates Description and Business Overview
Table 162. Vasodilators/Nitrates Heart Failure Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Vasodilators/Nitrates Heart Failure Therapeutics Product
Table 164. Vasodilators/Nitrates Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Heart Failure Therapeutics Distributors List
Table 168. Heart Failure Therapeutics Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Therapeutics Product Picture
Figure 2. Global Heart Failure Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Heart Failure Therapeutics Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Medical Research Organization Examples
Figure 9. Global Heart Failure Therapeutics Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Heart Failure Therapeutics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Heart Failure Therapeutics Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Heart Failure Therapeutics Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Heart Failure Therapeutics Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Heart Failure Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Heart Failure Therapeutics Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Heart Failure Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Heart Failure Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Heart Failure Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Heart Failure Therapeutics Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Heart Failure Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Heart Failure Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Heart Failure Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Heart Failure Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Heart Failure Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Heart Failure Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Heart Failure Therapeutics Players Market Share by Revenue in Heart Failure Therapeutics 2015 & 2019
Figure 27. Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Heart Failure Therapeutics Revenue Share by Type (2015-2020)
Figure 29. Global Heart Failure Therapeutics Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Heart Failure Therapeutics Revenue Share by Application (2015-2020)
Figure 31. Global Heart Failure Therapeutics Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Heart Failure Therapeutics Sales Market Share by Type in 2019
Figure 33. United States Heart Failure Therapeutics Sales Market Share by Type in 2019
Figure 34. Europe Heart Failure Therapeutics Sales Market Share by Company in 2019
Figure 35. Europe Heart Failure Therapeutics Sales Market Share by Type in 2019
Figure 36. Europe Heart Failure Therapeutics Sales Market Share by Application in 2019
Figure 37. China Heart Failure Therapeutics Sales Market Share by Company in 2019
Figure 38. China Heart Failure Therapeutics Sales Market Share by Type in 2019
Figure 39. China Heart Failure Therapeutics Sales Market Share by Application in 2019
Figure 40. Japan Heart Failure Therapeutics Sales Market Share by Company in 2019
Figure 41. Japan Heart Failure Therapeutics Sales Market Share by Type in 2019
Figure 42. Japan Heart Failure Therapeutics Sales Market Share by Application in 2019
Figure 43. Southeast Asia Heart Failure Therapeutics Sales Market Share by Company in 2019
Figure 44. Southeast Asia Heart Failure Therapeutics Sales Market Share by Type in 2019
Figure 45. Southeast Asia Heart Failure Therapeutics Sales Market Share by Application in 2019
Figure 46. India Heart Failure Therapeutics Sales Market Share by Company in 2019
Figure 47. India Heart Failure Therapeutics Sales Market Share by Type in 2019
Figure 48. India Heart Failure Therapeutics Sales Market Share by Application in 2019
Figure 49. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Cynokinetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Les Laboratoires Servier Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Procoralan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Cardiorentis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. CVie Therapeutics Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Orion Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. PhaseBio Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Market Segment by Product Type Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. B-Blockers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Calcium Channel Blockers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Cardiac Glycosides Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Diuretics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Morphine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Vasodilators/Nitrates Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Key Raw Materials Price Trend
Figure 68. Manufacturing Cost Structure of Heart Failure Therapeutics
Figure 69. Manufacturing Process Analysis of Heart Failure Therapeutics
Figure 70. Heart Failure Therapeutics Industrial Chain Analysis
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 73. Porter's Five Forces Analysis
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
うっ血性心不全（CHF）治療装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Congestive Heart Failure (CHF) Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.0% in the forecast period of 2020 to 2025 and will expected to reach USD 5753.1 million by 2025, from USD 5114.7 million …- 心構造疾患治療デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Structural Heart Disease Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The St…
- 先天性心臓欠損閉鎖装置の世界市場レポート2020 Market Analysis and Insights: Global Congenital Heart Defect Closure Devices Market The global Congenital Heart Defect Closure Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Congenital Heart Defe…
- 心拍数モニターの世界市場レポート2020 Heart rate monitors are the devices used for the continuous monitoring of heart rate or pulse. These devices can be wearable or non-wearable, embedded with sensors, the device tracks heart rate of a person during physical activities or rest. Heart rate monitoring is one of the major processes in dis…
- 骨がん診断・治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bone Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bone C…